In the aftermath of the acquisition by Novartis, there has been layoff after layoff of the most experienced employees. Of course this is done in order to cut costs to boost quarterly earnings so that stock prices remain as high as possible. While that strategy is aimed at keeping investors happy and executive bonuses high, it ultimately costs the company valuable knowledge and expertise that they simply cannot replace with the low cost employees that are hired after each of these layoffs. Needless to say, the moral of the remaining employees is poor due to the atmosphere of fear, uncertainty, and having to do much more work with both fewer people and less experience.
The Pharma division has already been absorbed by Novartis (the parts they wanted to keep anyway). It looks like Alcon will be divided and sold off piecemeal. I would guess that the device side of the company is being positioned for sale to another company and the OTC products such as lens care are on the block too. If that happens, there is not much need for the Fort Worth campus anymore.
